Jabbour SK, Cho BC, Bria E, Kato T, et al. KEYLYNK-012: A Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy (CCRT) Followed by Pembrolizumab With or Without Olaparib vs. CCRT Followed by Durvalumab in Unresectable, Locally Advanced, Stage III NonSmall-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34701460